Author:
Kelberman Michael A.,Vazey Elena M.
Funder
National Institute of Mental Health
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,Genetics,Biochemistry
Reference100 articles.
1. de Lau LML, Breteler MMB. Epidemiology of Parkinson’s disease. Lancet Neurol. 2006;5:525–35.
2. Kadastik-Eerme L, Muldmaa M, Lilles S, Rosenthal M, Taba N, Taba P. Nonmotor features in Parkinson’s disease: what are the most important associated factors? Parkinsons Dis. 2016;2016:4370674. There is a growing concern about negative health related impacts of non-motor symptoms for PD patients. This study showed almost universal prevalence of non-motor symptoms in PD as well as evidence that levodopa treatment is associated with a higher burden of non-motor symptoms.
3. Erro R, Roberto E, Marina P, et al. Non-motor symptoms in early Parkinson’s disease: a 2-year follow-up study on previously untreated patients. J Neurol Neurosurg Psychiatry. 2012;84:14–7.
4. Duncan GW, Khoo TK, Yarnall AJ, O’Brien JT, Coleman SY, Brooks DJ, et al. Health-related quality of life in early Parkinson’s disease: the impact of nonmotor symptoms. Mov Disord. 2014;29:195–202.
5. Shulman LM, Taback RL, Rabinstein AA, Weiner WJ. Non-recognition of depression and other non-motor symptoms in Parkinson’s disease. Parkinsonism Relat Disord. 2002;8:193–7.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献